Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients

Circulation

Volumn 100, Issue 13, 1999, Pages 1400-1405

  Taddei, Stefano ^a   Ghiadoni, Lorenzo ^b   Virdis, Agostino ^b   Buralli, Simona ^b   Salvetti, Antonio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Bradykinin; Endothelium derived factors; Free radicals; Hypertension; Nitric oxide; Ouabain

Indexed keywords

ASCORBIC ACID; BRADYKININ; N(G) METHYLARGININE; NITRIC OXIDE; OUABAIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG INHIBITION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPERPOLARIZATION; INTRAARTERIAL DRUG ADMINISTRATION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; VASODILATATION;

EID: 0033613094     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.13.1400     Document Type: Article

References (32)

1. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990:1-228.
3. Moncada S, Palmer RJM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
4. Cowan CL, Cohen RA. Two mechanisms mediate relaxation by bradykinin for pig coronary artery: NO-dependent and independent responses. Am J Physiol. 1991;261:H830-H835.
5. Mügge A, Lopez JAG, Piegors DJ, Breese KR, Heistad DD. Acetylcholine-induced vasodilation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am J Physiol. 1991;260:H242-H247.
6. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization-beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
7. + channels in arterial smooth muscle. Science. 1989;245:177-180.
8. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396:269-272.
9. Fèlètou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515-524.
10. Vallance P, Coller J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
11. Vita JA, Treasure CB, Nabel EG, Mclenacham JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
12. Kuga T, Egashira K, Mohri M, Tsutsui H, Harasawa Y, Urabe Y, Ando S, Shimokawa H, Takeshita A. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation. 1995;92:183-189.
13. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
14. Linder L, Kiowski W; Bühler FR, Lüscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
15. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
16. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
17. Panza JA; Garcμa CE, Kilcoyne CM, Quyyumi A, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
18. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilatation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
19. Vanhoutte PM, Auch Schwelk W, Biondi ML, Lorenz RR, Schini VB, Vidai MJ. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol. 1989;28 (suppl 2):95S-103S.
20. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1-27.
21. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1997;265:750-751.
22. Tonumura Y. (Na+, K+) ATPase in the plasma membrane. In: EnergyTransducing ATPase: Structure and Kinetics. Cambridge, UK: Cambridge University Press: 1986:240-281.
23. Malvano R, Zucchelli GC, Rosa U, Salvetti A. Measurement of plasma renin activity by angiotensin I radioimmunoassay I: an assessment of some methodological aspects. J Nucl Biol Med. 1972;16:24-31.
24. Lieberman J. Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med. 1975;59:365-372.
25. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377-6381.
26. Taddei S, Virdis A, Ghiadoni L, Mattei P, Salvetti A. Effects of ACE-inhibition on endothelium-dependent vasodilatation in essential hypertensive patients. J Hypertens. 1998;16:447-456.
27. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation. 1997;96:1513-1519.
28. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(part 2):274-279.
29. Vanhoutte PM, Fèlètou M, Boulanger CM, Höffner U, Rubanyi GM. Existence of multiple endothelium-derived relaxing factors. In: Vanhoutte PM, ed. Endothelium-Derived Hyperpolarizing Factor. Reading UK: Gordon & Breach Publishing Group: 1996:1-10.
30. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 1993;92:2867-2871.
31. Bauersachs J, Popp R, Hecker M, Sauer E, Flemin I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 1996;94:3341-3347.
32. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92: 2911-2918.